Company page
Genelux Corporation
Genelux Corporation (GNLX) is a public company based in America, with a market capitalization of approximately $132.95 million. The company focuses on developing innovative therapies for cancer treatment. Genelux is committed to advancing its research and development efforts to improve patient outcomes in oncology.
- Ticker
- GNLX:NASDAQ
- Asset type
- Stock
- Market cap
- $133.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD